Publications by authors named "A Daletzakis"

Claim this Profile
A
Advanced stage melanoma during pregnancy: recommendations from a retrospective, multicentre, registry-based study.
Jessica S W Borgers, Douglas B Johnson, Elisabeth Livingstone, Dirk Schadendorf, Elizabeth I Buchbinder, Antonios Daletzakis

EClinicalMedicine· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Final clinical analysis of pre-operative ipilimumab and nivolumab in locally advanced urothelial cancer and exploration of tumor-draining lymph node composition: The NABUCCO trial.
Chantal F Stockem, Jeroen van Dorp, Nick van Dijk, Daniel J Vis, Rolf Harkes, Antonios Daletzakis

Eur J Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimation of the Restricted Mean Duration of Response (RMDoR) in Oncology.
Antonios Daletzakis, Kit C B Roes, Marianne A Jonker

Pharm Stat· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intensified alkylating chemotherapy for patients with oligometastatic breast cancer harboring homologous recombination deficiency: Primary outcomes from the randomized phase III OLIGO study.
A van Ommen-Nijhof, T G Steenbruggen, T G Wiersma, S Balduzzi, A Daletzakis

Eur J Cancer· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 trial combining afatinib with cetuximab in patients with EGFR exon 20 insertion-positive non-small cell lung cancer.
Bianca A M H van Veggel, Anthonie J van der Wekken, Marthe S Paats, Lizza E L Hendriks, Sayed M S Hashemi, Antonios Daletzakis

Cancer· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis